IntelliPharmaCeutics Intl Inc (USA) (NASDAQ:IPCI) reported the results of operations for the three and nine months ended August 31, 2016. All dollar amounts referenced …
Brean Capital analyst Jonathan Aschoff came out today with a research note on Intellipharmaceutics (NASDAQ:IPCI), as the company announced a licensing agreement with Teva …
Maxim’s healthcare analyst Jason Kolbert is weighing in with an update on Intellipharmaceutics International (NASDAQ:IPCI), as the company announced the it has signed a license agreement …